Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.

Data de publicació: 05/11/2020 Data Ahead of Print: 05/11/2020

Autors de IIS La Fe

Miguel Armengot Carceller

Autor
Mª Jose Gomez Gomez

Autor
Noelia Múñoz Fernández

Autor
Alfonso José García Piñero

Autor

Autors aliens a IIS La Fe

García-Navalón C
Doménech-Campos E
Miguel AG
Marco-Algarra J
Palop-Cervera M

Grups d'Investigació

Biomedicina Molecular, Celular y Genómica

Leader

José María Millán Salvador

Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a clinical entity with specific features that impacts significantly on patient quality of life (QoL). CRSwNP is often associated with asthma and is difficult to control and manage despite pharmacological and/or surgical treatment. Omalizumab, a monoclonal anti-IgE antibody, has emerged as a putative therapeutic option.

Dades de la publicació

ISSN/ISSNe:: 1945-8924, 1945-8932
Tipus:: Article
Pàgines:: 516-524
DOI:: 10.1177/1945892420972326
PubMed:: 33153272
Factor d'Impacte:: 0,861 SCImago ℠
Quartil:: Q1 SCImago ℠

Documents

No hi ha documents

Mètriques

Filiacions

Armengot-Carceller M:: Otolaryngology Department, University and Polytechnic La Fe Hospital, Valencia, Spain

Department of Surgery, Valencia University, Valencia, Spain

Instituto de Investigación. Grupo de Biomedicina Molecular, Celular y Genómica (BMCG), Health Research Institute La Fe, Valencia, Spain

CIBER of Respiratory Diseases, Instituto de Salut Carlos III, Ministerio de Ciencia e Innovación, Madrid, Spain
Gómez-Gómez MJ:: Otolaryngology Department, University and Polytechnic La Fe Hospital, Valencia, Spain
García-Navalón C:: Department of Surgery, Valencia University, Valencia, Spain

Otolaryngology Department, University General Hospital of Valencia, University of Valencia, Valencia, Spain
Doménech-Campos E:: Otolaryngology Department, Arnau de Vilanova Hospital, Valencia, Spain
Muñoz-Fernández N:: Otolaryngology Department, University and Polytechnic La Fe Hospital, Valencia, Spain
Miguel AG:: Otolaryngology Department, Manises Hospital, Valencia, Spain
Marco-Algarra J:: Department of Surgery, Valencia University, Valencia, Spain

Otolaryngology Department, University Clinic Hospital of Valencia, Valencia, Spain
Palop-Cervera M:: Pulmonology Department, Sagunto Hospital, Valencia, Spain
Piñero AG:: Otolaryngology Department, University and Polytechnic La Fe Hospital, Valencia, Spain

Keywords

IgE, SNOT-22, aspirin-exacerbated respiratory disease, chronic rhinosinusitis with nasal polyps, mild asthma, nasal polyps, omalizumab, quality of life, tissue eosinophilia, total nasal endoscopic polyp score